Skip to main content

Table 2 Correlations between levels of p16, p27 expression and clinico-pathological characteristics

From: Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer

Variable

p16

p27

  

low

high

n

p value

low

high

n

p value

  

N

%

n

%

  

n

%

n

%

  

pre-op PSA

< 5

10

71.4

4

28.6

14

0.252

12

85.7

2

14.3

14

0.397

 

5-10

36

75

12

25

48

0.104

39

81.2

9

18.8

48

0.215

 

> 10

8

100

0

0

8

0.180

8

100

0

0

8

0.534

Gleason

score

≤ 7 (3+4)

21

72.4

8

27.6

29

0.565

25

86.2

4

13.8

29

1.000

 

≥ 7 (4+3)

33

80.5

8

19.5

41

 

34

82.9

7

17.1

41

 

pT stage

≤ 2

34

80.9

8

19.1

42

0.394

37

88.1

5

11.9

42

0.328

 

> 2

20

71.4

8

28.6

28

 

22

78.6

6

21.4

28

 

PSA relapse

no

24

72.7

9

27.3

33

0.572

27

81.8

6

18.2

33

1.000

 

yes

30

81.1

7

18.9

37

 

31

83.8

6

16.2

37

 
  1. pre-op PSA, pre-operative PSA; pT stage, pathologic TNM stage